Acta Medica
Journal of Faculty of Medicine in Hradec Králové 

Individual author index pages

• Ladislav Chrobák
• Milan Bláha

Other articles of these authors

• FIFTEEN YEARS OF SINGLE CENTER EXPERIENCE WITH STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA: A RETROSPECTIVE ANALYSIS

  Jakub Radocha, Vladimír Maisnar, Alžběta Zavřelová, Melanie Cermanová, Miriam Lánská, Miloslav Kmoníček, Ladislav Jebavý, Milan Bláha, Jaroslav Malý, Pavel Žák

  2013, Vol. 56, Issue 1, pp. 9-13
• Extracorporeal Elimination of Circulating Pegylated Liposomal Doxorubicin (PLD) to Enhance the Benefit of Cytostatic Therapy in Platinum-Resistant Ovarian Cancer Patients

  Ondřej Kubeček, Milan Bláha, Daniel Diaz-Garcia, Stanislav Filip

  2015, Vol. 58, Issue 1, pp. 3-8
• Therapeutic Erythrocytapheresis in the Initial Treatment of Hereditary Hemochromatosis

  Vít Řeháček, Milan Bláha, Hana Jiroušová, Jitka Černohorská, Petr Papoušek

  2012, Vol. 55, Issue 4, pp. 180-185
• Successful Treatment of Iron Overload with Phlebotomies in Two Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II)

  Ladislav Chrobák

  2006, Vol. 49, Issue 3, pp. 193-195
• Excess of Pappenheimer Bodies (Siderocytes) in Two Splenectomized Siblings with Congenital Dyserythropoietic Anemia – Type II (CDA-II) and Iron Overload

  Ladislav Chrobák, Jindřiška Matysová

  2004, Vol. 47, Issue 3, pp. 187-188
• To the Paper: What Are Appropriate Initial and Salvage Therapies for Patients with Thrombotic Thrombocyopenic Purpura (TTP)?

  Milan Bláha

  2004, Vol. 47, Issue 1, pp. 61-61
• Imatinib Mesylate (STI 571) – A New Oral Target Therapy For Chronic Myelogenous Leukemia (CML)

  Ladislav Chrobák, Jaroslava Voglová

  2003, Vol. 46, Issue 3, pp. 85-89
• Extracorporeal LDL-Cholesterol Elimination in the Treatment of Severe Familial Hypercholesterolemia

  Milan Bláha

  2003, Vol. 46, Issue 1, pp. 3-7
• Paroxysmal Nocturnal Hemoglobinuria (Membrane Defect, Pathogenesis, Aplastic Anemia, Diagnosis)

  Ladislav Chrobák

  2000, Vol. 43, Issue 1, pp. 3-8
• Minimal Residual Disease, Its Detection and Significance in Hairy-Cell Leukemia

  Pavel Žák, Ladislav Chrobák, Karel Dědič

  1999, Vol. 42, Issue 3, pp. 85-88
• Is Factor V Leiden a Risk Factor for Fetal Loss?

  Petr Dulíček, Ladislav Chrobák, Ivo Kalousek, Lenka Pešavová, Miroslav Pecka, Pravoslav Stránský

  1999, Vol. 42, Issue 3, pp. 93-96
• Red Cell Distribution Width (RDW) as a Marker of Disease Activity in Patients with Hairy Cell Leukemia

  Ladislav Chrobák, Pavel Žák, Karel Podzimek, Pravoslav Stránský

  1998, Vol. 41, Issue 1, pp. 23-26
• Long-Term Results in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine

  Ladislav Chrobák, Pavel Žák, Karel Podzimek, Lenka Plíšková, Jaroslava Foglová, Vladimír Maisnar, Petr Dulíček, Karel Dědič

  1997, Vol. 40, Issue 2, pp. 41-45